An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.

Researchers focus on reversing the scarring that’s common to liver diseases.

Our Global Head of Precision Medicine in Oncology discusses her day-to-day work at Novartis.

Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.

Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.

Jennifer Leeds offers a behind-the-scenes look at the consortia forming to address COVID-19.